Publication | Closed Access

Normal aging in rats and pathological aging in human Alzheimer’s disease decrease FAAH activity: Modulation by cannabinoid agonists

Cannabis UseNeurodegenerative DiseasesAlzheimer's DiseaseAgingMedicinePathological AgingHuman Alzheimer ’Cannabinoid AgonistsNeuropharmacologyNeurologyNeuroscienceAging-associated DiseasePharmacologyCannabinoid Pharmacology